Galanin inhibits acetylcholine release from rat cerebral cortex via a pertussis toxin-sensitive G(i) protein

Neuropeptides

Volumn 33, Issue 3, 1999, Pages 197-205

  Wang, H Y ^a   Wild, K D ^a   Shank, R P ^a   Lee, D H S ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GALANIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SYNAPTOSOME; CONTROLLED STUDY; EVOKED RESPONSE; HORMONAL REGULATION; HORMONE ACTION; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0032793190     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0024     Document Type: Article

References (53)

1. Bartfai T., Hökfelt T., Langel U. Galanin-A neuroendocrine peptide. Critical Rev Neurobiol. 7:1993;229-274.
2. 125I-galanin binding sites in the rat central nervous system. J Chem Neuroanat. 1:1988;213-233.
3. Köhler C., Hallman H., Mclander T., Hökfelt T., Norheim E. Autoradiographic mapping of galanin receptors in the monkey brain. J Chem Neuroanat. 2:1989;269-284.
4. Chen Y., Laburthe M., Amiranoff B. Galanin inhibits adenylate cyclase of rat brain membranes. Peptides. 13:1992;339-341.
5. Amiranoff B., Lorinet A-M., Lagny-Pourmir I., Laburthe M. Mechanism of galanin-inhibited insulin release: occurrence of a pertussis toxin-sensitive inhibition of adenylate cyclase. Eur J Biochem. 177:1988;147-152.
6. Kinney G. A., Emmerson P. J., Miller R. J. Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus. J Neurosci. 18:1998;3489-3500.
7. Wiesenfeld-Hallin Z., Xu X., Hao J-X., Hökfelt T. The behavioral effects of intrathecal galanin on tests of thermal and mechanical nociception in the rat. Acta Physiol Scad. 147:1993;457-458.
8. Corwin R. L., Robinson J. K., Crawley J. N. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala. Eur J Neurosci. 5:1993;1528-1533.
9. Berthold M., Bartfai T. Galanin receptors: involvement in feeding, pain, depression and Alzheimer's disease. Life Sci. 60:1997;1523-1533.
10. Lorimer D. D., Matkowskj K., Benya R. V. Cloning, chromosomal location, and transcriptional regulation of the human galanin-1 receptor gene (GALN1R). Biochem Biophys Res Commun. 241:1997;558-564.
11. Wang S., He C., Hashemi T., Bayne M. Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes. J Biol Chem. 72:1997;31949-31952.
12. Bloomquist B. T., Beauchamp M. R., Zhelnin L. Cloning and expression of the human galanin receptor GalR2. Biochem Biophys Res Commun. 243:1998;474-479.
13. Chen Y., Fournier A., Couvineau A., Laburthe M and Amiranoff B. Purification of a galanin receptor from pig brain. Proc Natl Acad Sci USA. 90:1993;3845-3849.
14. Crawley J. N. Co-existence of neuropeptides and 'classical' neurotransmitters. Functional interactions between galanin and acetylcholine. Ann NY Acad Sci. 579:1990;233-245.
15. Fisone G., Wu C. F., Consolo S. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: Histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci USA. 84:1987;7339-7343.
16. Consolo S., Baldi G., Russi G., Givenni G., Bartfai T., Vezzani A. Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc Natl Acad Sci USA. 91:1994;8047-8051.
17. Fisone G., Bartfai T., Nilsson S., Hökfelt T. Galanin inhibits potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Res. 568:1991;279-284.
18. Robinson J. K., Crawley J. N. Intraventricular galanin impairs delayed non-matching to sample performance in rats. Behav Neurosci. 107:1993;458-467.
19. Crawley J. N. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Life Sci. 58:1996;2185-2199.
20. Wang H-Y., Yue T-L., Feuerstein G., Friedman E. Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein. J Neurochem. 63:1994;1720-1725.
21. Gray E. G., Whittaker U. P. The isolation of nerve endings from brain: an electron microscopic study of cell fragments derived by homogenization and centrifugation. J Anat. 96:1962;79-87.
22. Bartfai T., Bedecs K., Land T. M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus ceruleus, and spinal cord. Proc Natl Acad Sci USA. 88:1991;10961-10965.
23. Gillison S. L., Sharp G. W. G. ADP ribosylation by cholera toxin identifies three G-proteins that are activated by the galanin receptor: studies with RINm5F cell membranes. Diabetes. 43:1994;24-32.
24. 125I]galantide. J Pharmacol Exp Ther. 275:1995;720-727.
25. Kar S., Seto D., Gaudreau P., Quirion R. β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal formation. J Neurosci. 16:1996;1034-1040.
26. Kar S., Issa A. M., Seto D. Amyloid β-peptide inhibits high affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem. 70:1998;2179-2187.
27. Parker E. M., Izzarelli D. G., Nowak H. P. Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells. Mol Brain Res. 34:1995;179-189.
28. Lorimer D. D., Benya R. V. Cloning and quantitation of Galanin-1 receptor expression by mucosal cell lining the human gastrointestinal tract. Biochem Biophys Res Comm. 222:1996;379-385.
29. McDermott A. M., Sharp G. W. G. Gi2 and Gi3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell. Diabetes. 44:1995;453-459.
30. Hashemi T., Fried S., Clemmons A. L., Hawes B. E. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry. 37:1998;6711-6717.
31. Kalkbrenner F., Degtiar V. E., Schenker M. Subunit composition of Go proteins functionally coupling galanin receptors to voltage-gated calcium channels. EMBO J. 14:1995;4728-4737.
32. Degtiar V. E., Harhammer R., Nuernberg B. Receptors couple to L-type calcium channels via distinct Go proteins in rat neuroendocrine cell lines. J Physiol. 502:1997;321-333.
33. Cormont M., Le Marchand-Brustel Y., Van Obberghen E., Spiegel A. M., Sharp G. W. G. Identification of G protein α-subunits in RINm5F cells and their selective interaction with galanin receptor. Diabetes. 40:1991;1170-1176.
34. Benelli A., Arletti R., Bertolini A., Menozzi B., Basaglia R., Poggioli R. Galantide stimulates sexual behavior in male rats. Eur J Pharmacol. 260:1994;272-282.
35. Oegren S. O., Pramanik A., Land T., Lagel U. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release. Eur J Pharmacol. 241:1993;59-64.
36. Bartfai T., Bedecs K., Land T. M-15: high affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus ceruleus, and spinal cord. Proc Natl Acad Sci USA. 88:1991;10961-10965.
37. Mazzocchi G., Rebuffat P., Gottardo G., Luseppe M., Ludwik K., Nussdorfer G. G. Galanin stimulates glucocorticoid secretion in rats through a receptor-dependent activation of the adenylate cyclase/protein kinase A-dependent signaling pathway. Peptide (N.Y.). 19:1998;891-895.
38. Mulvaney J. M., Merriam L. A., Parsons R. L. Galantide distinguishes putative subtypes of galanin receptors in mudpuppy parasympathetic neurons. Eur J Pharmacol. 287:1995;97-100.
39. Zhang X., Dagerlind A., Bao L., Lundberg R. R. J. J. M., Hökfelt T. Increased expression of galanin in the rat superior cervical ganglion after pre- and postganglionic nerve lesions. Exp Neurol. 127:1994;9-22.
40. Mufson E. J., Cochran E., Benzing W., Kordower J. H. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging. Alzheimer's disease and Down's syndromes. Dementia. 4:1993;237-250.
41. Bedecs K., Berthold M., Bartifai T. Galanin: 10 years with a neuroendocrine peptide. Int J Biochem Cell Biol. 27:1995;337-349.
42. Bartfai T., Langel U. Galanin receptor ligands as potential therapeutic agents in depression and neurodegeneration. Eur J Med Chem. 30 (Suppl.):1995;163s-174s.
43. Dutar P., Lamour Y., Nicoll R. A. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Eur J Pharmacol. 164:1989;355-360.
44. Lamour Y., Senut M. C., De Bilbao F., Potier B., Dutar P., Hökfelt T., Bartfai T., Jacobowitz D. The functions of galanin in the septo-hippocampal system of the adult and the aged rat: electrophysiological and anatomical observations. (Eds.), Galanin-A New Multifunctional Peptide in the Neuroendocrine System, vol. 58. 1990;Proc Int Symp., Wenner-Gren Center, Stockholm, Cambridge, Cambridge University Press, pp. p. 357-366.
45. Pieribone V. A., Xu Z.-Q., Zhang X., Grillner S., Bartfai T., Hökfelt T. Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neurosci. 64:1995;861-874.
46. Hökfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17:1994;22-30.
47. Henken D. B., Martin J. R. The proportion of galanin-immunoreactive neurons in mouse trigeminal ganglia is transiently increased following corneal innoculation of herpes simplex virus type-1. Neurosci Lett. 140:1992;177-180.
48. Ohno K., Takeda N., Kiyama H., Kubo T Tohyama M. Occurrence of galanin-like immunoreactivity in vestibular and cochlear efferent neurons after labyrinthectomy in the rat. Brain Res. 644:1994;135-143.
49. Agoston D. V., Komoly S., Palkovits M. Selective up-regulation of neuropeptide synthesis by blocking the neuronal activity: galanin expression in septohippocampal neurons. Exp Neurol. 126:1994;247-255.
50. Ogren S. O., Hökfelt T., Kask K., Langel U., Bartfai T. Evidence for a role of the neuropeptide galanin in spatial learning. Neurosci. 52:1992;1-5.
51. McDonald M. P., Crawley J. N. Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed-nonmatching-to-position task. Behav Neurosci. 110:1996;1025-1032.
52. McDonald M. P., Willard L. B., Wenk G. L., Crawley J. N. Co-administration of galanin antagonist M40 with a muscarinic M-1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions. J Neurosci. 18:1998;5078-5085.
53. Mastropaolo J., Nadi N. S., Ostrowski N. L., Crawley J. N. Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proc Natl Acad Sci USA. 85:1988;9841-9845.